Skip to content

Kura Oncology KURA Change in Inventories

Change in Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$431M+195%
Amgen logo
AmgenAMGN
-$18M+93.8%
Exelixis logo
ExelixisEXEL
$3.39M+4,673%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06M-50.8%
AbbVie logo
AbbVieABBV
$184M+18.7%
Incyte logo
IncyteINCY
$12.23M-57.2%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$919.7M+81.6%
Enterprise value$904.89M+90.7%
P/S12.8×+3.5×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's change in inventories?
Kura Oncology (KURA) reported change in inventories of $430K in Q1 2026.
How has Kura Oncology's change in inventories changed year-over-year?
Kura Oncology's change in inventories increased by 316.5% year-over-year, from $103.25K to $430K.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.